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Introduction  
The UK is the first, and so far only, country to pass explicit legislation allowing for 
the licensed use of a new reproductive technology: mitochondrial replacement 
techniques (MRTs) (The Human Fertilisation and Embryology (Mitochondrial 
Donation) Regulations 2015). These techniques may potentially prevent the 
transmission of mitochondrial DNA diseases. They are controversial because they 
involve the manipulation of oocytes, or embryos, and the transfer of genetic material. 
Some commentators have even suggested that MRTs constitute germline genome 
modification, a prospect which has long been the subject of ethical concern 
(González-Santos 2017). 
While the ethical issues raised by MRTs continue to provoke academic debate, the 
UK has already granted the first license, of a two-step scheme, to Newcastle Fertility 
Centre; a second license now needs to be granted to a specific patient, which is yet to 
happen (Human Fertilisation and Embryology Authority 2017). Although the 2016 
US Institute of Medicine’s report on the ethical aspects of MRTs asserted that they 
are ethically permissible albeit limited to male embryos to avoid germline 
transmission, the FDA has been barred from even acknowledging the receipt of 
applications to carry them out (Adashi and Cohen 2017). It appears that this situation 
will not change under the Trump administration. 
Given these antecedents, all eyes were on the UK as the most likely location for the 
first MRT birth, so it was a shock to the scientific community and the world at large 
when, on 27 September 2016, it was announced that the first MRT baby had already 
been born (Hamzelou 2016). US-based scientist Dr John Zhang used maternal spindle 
transfer (one of the recognised methods of MRTs, see Craven et al. (2017)) to 
generate five embryos for a woman carrying oocytes with deleterious mutations of the 
mitochondrial DNA in New York City. Zhang then shipped the only euploid embryo 
to Mexico, where it was transferred to the mother’s uterus. The baby was born in 
April 2016 and is apparently doing well. 
While this is a happy result for the new family, the consequences of Zhang’s actions, 
crossing borders to achieve an early first in this field, will continue to be felt and have 
implications for: i) health research in Mexico, ii) the reproductive rights of Mexicans, 
and iii) the global politics of science. Medical tourism, in which patients travel 
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outside the country where they reside in order to seek medical care, has received 
much ethical attention; Zhang’s actions, travelling outside his country to carry out 
experimental procedures, represent a form of ‘scientific tourism’ which has not been 
properly ethically explored.  In this commentary we suggest, taking Mexico as an 
example, that this particular mode of scientific tourism can have seriously detrimental 
effects for developing countries. An awareness of the consequences of these events in 
the global context is essential as we continue to contemplate policy in this 
‘controversial’ area.  
Local Adverse Effects 
The first and most immediate concern is the potential for local adverse effects on 
reproductive health and the regulation of research. In Mexico, a country with a strong 
conservative presence, embryo research and reproductive health are highly contested 
areas. For example, the political influence of the Catholic Church, and the extensive 
lobbying and protests led by conservative organisations such as the National Family 
Front, have had a significant impact on legislators in this area. Since 2007, several 
state constitutions around the country have been changed to protect human life from 
the moment of conception (i.e. implantation) or fertilization (Altamirano 2016; 
Beauregard 2016, 2017). 
  
Access to reproductive health technologies and scientific research in this area are thus 
already in a precarious position. In light of current moves to revise and clarify the 
federal laws governing assisted reproduction, and the use of human embryos, the 
revelation of Zhang’s work may have especially damaging effects (Reardon 2016). 
The negative publicity directed at this event on the international stage and the 
associated vilification of Mexico as a country with lax regulation provides 
ammunition to conservative groups who are seeking to make the law more restrictive 
(Palacios-González 2016). 
 
Further, an absence of explicit regulation does not necessarily mean “anything goes” 
or that there is no will to regulate. In some cases, a deliberate legal lacuna can itself 
be a form of regulatory compromise pro tem (Luna and Salles 2010); in others, such 
as in Mexico, regulation is a debate in progress, moving forward as the result of 
complex negotiation between competing positions with high political capital. Short-
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circuiting this process by taking advantage of interim uncertainties threatens to disrupt 
this delicate balance and foster a regulatory backlash.  
It might be argued that scientific tourism can have beneficial effects for local science, 
if training and technology transfer contribute to local capacity-building. In this case, 
however, given that Zhang’s team only intends to transfer the embryos in Mexico 
while carrying out the MRT procedures in the US, this seems unlikely. Zhang recently 
stated that: “For now, our nuclear transfer technique is very much like an iPhone 
that’s designed in California and assembled in China” (Mullin 2017). This does not 
indicate much intention to promote development of Mexican science. 
Consequences for the Long-Term Development of Science 
Beyond these immediate consequences, scientific tourism can have wider 
implications for the long-term development of science in under-resourced destination 
countries. If regulation becomes more restrictive as a result of scientific tourism, local 
scientists will be unable to pursue their research in their home country. Given that 
scientists in these countries often lack sufficient resources to engage in scientific 
tourism themselves, the net effect will be to block or substantively delay their work 
altogether, as has happened to the first Mexican scientist to derive an embryonic 
stem-cell line in Mexico (Reardon 2016). The adverse impact of this could be thus 
threefold. First, it contributes to the brain drain of developing countries, with 
associated adverse effects in local scientific communities and health resources. 
Second, it further disadvantages scientists in countries where research already lacks 
support, or is hampered by unclear regulation. Third, it affects a country’s overall 
scientific competitiveness in the long term. This, obviously, creates a clear problem of 
global scientific justice. 
The response to Zhang’s work also reflects a deeper problem of what we might call 
‘scientific chauvinism’, whereby criteria for scientific practice, regulatory standards 
and the terms of public discourse over science are dictated by the dominant scientific 
community. Deviations, which often fall out along cultural and political boundaries, 
are automatically classified as unscientific, unethical or unacceptable (Sipp and Pei 
2016). However, in the case of Mexico it is not a matter of different ethical standards: 
the moral sensitivity of this area of research and the need for regulation and oversight 
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is recognised in Mexico, even if the response to that need has so far been less than 
effective. Advisory groups in both the UK and US, and much of the bioethics 
literature, have deemed the technique to be ethically acceptable, at least in principle. 
Zhang’s move to Mexico for the embryo transfer process was therefore more a matter 
of escaping local oversight than going against ethical prescriptions. Should blame for 
this be attributed solely to the inadequacy of Mexican regulation? 
We suggest that this mode of allocating responsibility for scientists’ conduct reveals a 
problem in attitudes to global science and governance. When ethical questions arise 
about research in more developed countries, the assumption is generally that the 
scientist must have done something wrong, while the regulatory system and scientific 
culture is only a secondary object of scrutiny. The mainstream coverage of the ethical 
problems that emerged in relation to Paolo Macchiarini’s work on tissue-engineering 
transplants, for example, focused principally on his character and actions and the 
individual roles of others who enabled his actions, rather than on Sweden’s scientific 
culture and its regulatory and governance systems (Abbott 2016). 
 
When controversial or ethically dubious work is revealed in countries such as Mexico, 
on the other hand, the first assumption is often that there is something wrong with the 
system, be it insufficient regulation, inadequate oversight or inappropriate ethical 
standards. Most commentators took on face value Zhang’s statement that in Mexico 
“there are no rules” (Hamzelou 2016). In fact, Mexico does have rules regarding both 
research oversight and assisted reproduction; indeed, it is possible that Zhang’s team 
violated federal regulations on medical research(Palacios-González and Medina-
Arellano 2017; Ishii 2017). Focusing solely on Mexico’s apparent failure to conform 
to the standards of ethics and regulation upheld in supposedly more developed 
countries deflects attention from the responsibilities of scientists and reinforces biased 
attitudes about global ethical standards and the governance of science. We may draw 
a comparison here with gene editing and the ethical scepticism expressed towards the 
Chinese studies published on embryo gene editing. Such attitudes reflect the 
perception of a ‘Wild East’ with inferior ethical standards and inadequate regulation, 
an assumption that is not necessarily justified (Sipp and Pei 2016). 
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Finally, the MRTs situation also illustrates a problem of justice with respect to 
regulatory capacity. Scientific tourism can impose an unfair oversight burden on 
countries where ethics and governance structures for these technologies are under 
development. Researchers who travel to take advantage of an already overloaded 
system are unjustifiably increasing the burden of local oversight in order to further 
their own academic and otherwise interests. If we consider that the scientific ‘brain 
drain’ (of human resources) or ‘biopiracy’ (of genetic or biological resources) are 
problems for global scientific justice, then siphoning off oversight resources by 
engaging in scientific tourism ought equally to be regarded as problematic.  
 
There is, though, one possible positive outcome of this event for Mexico. Spurred by 
worldwide attention to Zhang’s work, a national debate on assisted reproduction that 
includes scientists, stakeholders and bioethicists might ensue, leading to an adequate 
regulatory framework that does not stifle scientific advancement. This possibility is 
remote at present due to Mexico’s political climate, but it is one that we must try to 
promote. 
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